Christian Zirbes

Christian Zirbes

Auto-generated profile, based on publicly available information

Christian Zirbes

Duke University School of Medicine, Durham, North Carolina, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 August 2025 in Injury
Verified
Journal Article
Closed access
DSDevika A. Shenoy
Devika A. Shenoy
SSSummer Shabana
Summer Shabana
EHEvelyn Hunter
Evelyn Hunter
CZChristian Zirbes
Christian Zirbes
SKSimran Khanna
Simran Khanna
ACAnthony A. Catanzano
Anthony A. Catanzano

29 April 2022 in Journal of Cystic Fibrosis
Verified
Journal Article
Closed access
CZChristian F. Zirbes
Christian F. Zirbes
NPNicholas J. Pitcher
Nicholas J. Pitcher
JDJoseph C. Davis
Joseph C. Davis
ABAlyssa R. Bartels
Alyssa R. Bartels
JKJustin D. Krogh
Justin D. Krogh
AFAnthony Fischer
Anthony Fischer

31 July 2025 in BMJ Open Quality
Verified
Journal Article
Open access
PDF file
DSDevika A Shenoy
Devika A Shenoy
KRKathryn Radulovacki
Kathryn Radulovacki
CZChristian Zirbes
Christian Zirbes
RSRachelle Shao
Rachelle Shao
GYGiussepe Yanez
Giussepe Yanez
ACAnthony A Catanzano
Anthony A Catanzano
Introduction: Paediatric patients with elevated healthcare needs have limited access to care, contributing to insufficient preventive services. Social drivers of health (SDOH), such as inadequate nutrition and poor community support, contribute substantially to paediatric health. In order to promote value-based healthcare, specialty providers like orthopaedic surgeons can serve as an entry point to connect patients to SDOH and primary care resources. The purpose of this short report is to provide a framework for other institutions for an ongoing screening programme. Overview of programme: Informed on prior initiatives, we designed a systematic screening programme for SDOH, obesity (via body mass index (BMI)) and primary care access in a paediatric orthopaedics clinic, for English-speaking and Spanish-speaking patients <18 years old. We record age, sex, race/ethnicity, language, orthopaedic condition, Area Deprivation Index and Childhood Opportunity Index from the electronic record previsit. BMI ≥95th percentile triggers referral to a paediatric obesity management programme. An institutional SDOH screen detects financial, food, transportation, housing and utility needs. A positive screen triggers a referral to institution and state-specific resources. A five-question Primary Care Access Screen identifies gaps in primary care access. A positive screen triggers an internal referral to paediatric primary care. Patients are flagged before visits, and screening results are reviewed. Students place referrals for positive screens, finalised by providers. Follow-up occurs at 6 weeks. Data collection: We assess screen positivity, referral uptake and completed appointments for all patients at 6 weeks.

9 January 2025 in Pediatric Pulmonology
Verified
Journal Article
Open access
CZChristian F. Zirbes
Christian F. Zirbes
AFAndries Feder
Andries Feder
APAnthony J. Pamatmat
Anthony J. Pamatmat
ABAlyssa R. Bartels
Alyssa R. Bartels
NPNicholas J. Pitcher
Nicholas J. Pitcher
AFAnthony Fischer
Anthony Fischer
Background: People with cystic fibrosis (CF) may not expectorate sputum at young ages or after they receive CFTR modulators. While oropharyngeal swabs are commonly used to test for lower airway pathogens, it is unknown whether Staphylococcus aureus from the oropharynx matches the strain(s) infecting the lungs. Our goal was to determine whether oropharyngeal and sputum isolates of S. aureus are genetically distinct in a cohort of patients with CF. Methods: We obtained historical S. aureus isolates from patients who intermittently expectorated sputum in 2018, and we prospectively cultured S. aureus from oropharyngeal swabs and sputum from subjects with CF between August 2020 and February 2022. We performed short‐read whole genome sequencing, determined sequence type, and performed phylogenetic analysis using S. aureus core genome single nucleotide polymorphisms (SNPs). We assigned isolates from a patient to the same strain if they had the same sequence type and differed by ≤ 60 SNPs or the isolates were not disturbed by clade breaker analysis. Results: 36 subjects had S. aureus in ≥ 1 oropharyngeal swab and ≥ 1 sputum in 2018. In the prospective collection, 31 subjects had synchronous oropharyngeal swab and sputum collections. Although polyclonal infections were detected, sputum and oropharyngeal isolates of S. aureus typically matched the same strain within study subjects, both over the span of 2018 (31/36 patients) and when collected simultaneously from 2020 to 2022 (29/31 patients). Conclusions: In patients with CF who intermittently produce sputum, oropharyngeal swabs identify S. aureus with genetic and phenotypic similarity to those cultured from sputum.

15 October 2021 in Journal of Cystic Fibrosis
Verified
Journal Article
Closed access
NPN. Pitcher
N. Pitcher
CZC. Zirbes
C. Zirbes
AMAhmed Moustafa
Ahmed Moustafa
PPP. Planet
P. Planet
ATAndrea Ries Thurman
Andrea Ries Thurman
AFA. Fischer
A. Fischer

11 March 2026 in Orthopaedic Journal of Sports Medicine
Verified
Journal Article
Open access
ATAaron Daniel Therien
Aaron Daniel Therien
TKTimothy Kouo
Timothy Kouo
IPIsabel Prado
Isabel Prado
ELEmily J. Luo
Emily J. Luo
CWCooper Williams
Cooper Williams
BLBrian C. Lau
Brian C. Lau
Background: Quadriceps tendon autografts are increasingly used for anterior cruciate ligament reconstruction (ACLR), harvested either with a patellar bone block (quadriceps tendon bone block [QTBB]) or as an all–soft tissue graft (quadriceps tendon soft tissue [QTST]). However, comparative data on outcomes remain limited and heterogeneous. Hypothesis: It was hypothesized that there would be no significant differences in patient-reported outcomes, objective stability, return to sports, or complication rates between QTBB and QTST grafts used for primary ACLR. Study Design: Systematic review and meta-analysis; Level of evidence, 4. Methods: A systematic review of 4 databases (PubMed, Embase, Scopus, and SportDISCUS) was conducted through November 2024. Studies reporting outcomes after primary ACLR using QTBB or QTST autografts were included (Levels 1-4 evidence). Random-effects meta-analyses pooled outcomes for each graft; meta-regression compared grafts while adjusting for follow-up duration and publication year. Risk of bias was assessed using Risk Of Bias In Non-randomized Studies of Interventions (ROBINS-I), and certainty of evidence was evaluated using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) framework. Results: A total of 44 studies (n = 2083; QTBB = 1104; QTST = 979) met the inclusion criteria with a mean follow-up of 29 months. International Knee Documentation Committee scores averaged 79.7 (95% CI, 74.8-84.6) for QTBB and 85.4 (95% CI, 80.9-89.8) for QTST autografts (β = 5.2; P = .11). There were no significant between-group differences in Lysholm, Tegner, or Knee injury and Osteoarthritis Outcome Score subscale scores. Instrumented laxity (KT-1000/2000) was higher for QTBB (1.75 mm [1.30-2.21]) versus QTST grafts (0.50 mm [0.35-0.65]) (β = −1.25 mm; P = 0.087), although this difference was not statistically significant and QTST results were driven by a single high-volume cohort. No significant differences were found in Lachman, pivot-shift, or anterior drawer grades. Return to sports (RTS) rates were 82% for QTBB and 81% for QTST grafts ( P = .82). Graft failure (both 6%), anterior knee pain (8% vs 7%), and infection (~1%) rates were comparable (all P > .70). Heterogeneity was high for patient-reported outcome measures ( I 2 >75%) but low for complications. Most studies had a moderate risk of bias, and the certainty of evidence was graded as very low across outcomes due to inconsistency, imprecision, and the observational nature of included studies. Conclusion: This systematic review and meta-analysis found no clinically meaningful differences in short-term patient-reported outcomes, graft integrity, RTS rates, or complications between QTBB and QTST grafts in primary ACLR.